PolyBatics

PolyBatics is a New Zealand biotechnology company developing and commercializing a biobead platform based on natural polymer nanoparticles with functional proteins attached. Its technology is positioned primarily as a bioprocessing and research tool, including disposable affinity chromatography media and custom functional nanoparticles used to purify therapeutics, nutraceuticals, and other biologically derived products. The platform originated from research by Professor Bernd Rehm at Massey University and is described as enabling single-step production or purification workflows compared with more conventional multi-step approaches. PolyBatics has also highlighted longer-term applications in vaccines, diagnostics, and drug delivery. The company appears to be private and active, with registered status in New Zealand and grant-backed funding.